Shared Resource Group 2: Preclinical and Clincal Science

$719,826P30FY2018CANIH

St. Jude Children'S Research Hospital, Memphis TN

Investigators

Linked publications & trials

Paper 39771507 Paper 39690832 Paper 39688234 Paper 39638997 Paper 39636306 Paper 39618286 Paper 39606455 Paper 39589268 Paper 39557842 Paper 39543288 Paper 39528457 Paper 39499026 Paper 39485718 Paper 39485483 Paper 39479326 Paper 39464253 Paper 39431920 Paper 39421891 Paper 39417586 Paper 39406246 Paper 39399669 Paper 39396041 Paper 39383878 Paper 39361286 Paper 39358389 Paper 39345580 Paper 39331734 Paper 39316649 Paper 39313329 Paper 39288319 Paper 39272842 Paper 39226322 Paper 39196461 Paper 39181868 Paper 39163487 Paper 39154228 Paper 39151742 Paper 39146822 Paper 39143224 Paper 39141861 Paper 39136313 Paper 39131398 Paper 39121442 Paper 39101835 Paper 39100716 Paper 39086133 Paper 39085996 Paper 39056576 Paper 39047240 Paper 39047169 Paper 39034595 Paper 39026748 Paper 39018245 Paper 39014081 Paper 39010649 Paper 39010279 Paper 38986959 Paper 38981063 Paper 38970612 Paper 38963825 Paper 38941494 Paper 38937803 Paper 38935785 Paper 38935023 Paper 38905595 Paper 38905576 Paper 38890386 Paper 38885332 Paper 38883748 Paper 38880379 Paper 38856684 Paper 38837897 Paper 38821086 Paper 38782142 Paper 38778453 Paper 38760116 Paper 38757485 Paper 38741226 Paper 38738881 Paper 38730616 Paper 38728029 Paper 38715372 Paper 38713463 Paper 38712935 Paper 38702309 Paper 38698126 Paper 38693155 Paper 38685057 Paper 38684680 Paper 38676662 Paper 38664416 Paper 38658803 Paper 38652878 Paper 38652494 Paper 38649740 Paper 38608806 Paper 38607410 Paper 38593228 Paper 38581226 Paper 38567652

Abstract

The Molecular Clinical Trials Shared Resource (MCTSR) is a highly-specialized resource that provides expert advice and technological and experimental support for the conduct of molecular assays of drug targets and drug activity within prospective clinical trials. The MCTSR, collects, processes and analyzes samples from patients treated within prospective clinical trials of molecular targeted therapies. Resource support extends throughout the entire research process from initial study design and planning through to the implementation and interpretation of results. The MCTSR is currently supporting 17 clinical trials within the SJCCC and cooperative groups and is engaging all four SJCCC programs that treat patients. During the current reporting period the resource provided molecular biology services to papers reporting seven Phase I clinical trials and five Phase II studies, of which seven were published in the Journal of Clinical Oncology. The resource contributed major molecular biology services to a further nine papers, including studies published in Nature, Nature Medicine, and Cancer Cell.

View original record on NIH RePORTER →